Anticancer activity of metal complexes: involvement of redox processes.
about
Anticancer activity of methyl-substituted oxaliplatin analogs.Kinetic and mechanistic studies on reactions of diruthenium(II,III) with biologically relevant reducing agents.Copper(ii) thiosemicarbazone complexes induce marked ROS accumulation and promote nrf2-mediated antioxidant response in highly resistant breast cancer cells.Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.A selenosemicarbazone complex with copper efficiently down-regulates the 90-kDa heat shock protein HSP90AA1 and its client proteins in cancer cells.Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patientsInteraction of a ruthenium hexacationic prism with amino acids and biological ligands: ESI mass spectrometry and NMR characterisation of the reaction products.Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cellsCopper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen speciesThe potent oxidant anticancer activity of organoiridium catalysts.Oxidative stress-related genetic polymorphisms are associated with the prognosis of metastatic gastric cancer patients treated with epirubicin, oxaliplatin and 5-fluorouracil combination chemotherapy.Effect of 2-chloro-substitution of adenine moiety in mixed-ligand gold(I) triphenylphosphine complexes on anti-inflammatory activity: the discrepancy between the in vivo and in vitro models.Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimicsTransfer hydrogenation catalysis in cells as a new approach to anticancer drug design.Pro-Oxidant Activity of Amine-Pyridine-Based Iron Complexes Efficiently Kills Cancer and Cancer Stem-Like CellsPotent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era.Cobalt derivatives as promising therapeutic agentsOrganometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance CircumventionDicopper(II) and dizinc(II) complexes with nonsymmetric dinucleating ligands based on indolo[3,2-c]quinolines: synthesis, structure, cytotoxicity, and intracellular distribution.The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivoAnticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.Cobalt and nickel stabilize stem cell transcription factor OCT4 through modulating its sumoylation and ubiquitination.Capillary electrophoretic methods in the development of metal-based therapeutics and diagnostics: new methodology and applications.Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives.The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro.Pt-based drugs: the spotlight will be on proteins.Redox- and non-redox-metal-induced formation of free radicals and their role in human disease.Metal complexes in cancer therapy - an update from drug design perspective.Structurally related hydrazone-based metal complexes with different antitumor activities variably induce apoptotic cell death.Innocent But Deadly: Nontoxic Organoiridium Catalysts Promote Selective Cancer Cell Death.GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer.Cytotoxicity of Manganese (III) Complex in Human Breast Adenocarcinoma Cell Line Is Mediated by the Generation of Reactive Oxygen Species Followed by Mitochondrial Damage.A survey of the mechanisms of action of anticancer transition metal complexes.Dual targeting of the thioredoxin and glutathione systems in cancer and HIV.The effect of potential supramolecular-bond promoters on the DNA-interacting abilities of copper-terpyridine compounds.Evaluation of cytotoxic activity of titanocene difluorides and determination of their mechanism of action in ovarian cancer cells.Electrochemical analysis of a novel ferrocene derivative as a potential antitumor drug.
P2860
Q30515979-C2C0A735-61F8-4BBC-BFAE-2B3015DDC3B0Q30670864-9B425DB3-3CAE-4BB1-91DD-36908341C9E5Q31172464-64C3E95A-977D-4390-808F-52D10441D5C0Q33763765-C1C428AA-A8AA-4F7E-9EC0-C6F788AD838CQ34208541-FBF683E3-9DBD-4FAB-BBFC-D8B28A554A6CQ34272841-99CF1177-9EE6-43BB-A292-41B296F9BDFEQ34327703-AA17AC09-58E5-4E05-BA56-1884B7169DC2Q34373124-A1715710-996E-4A32-AAB7-BCFE8BA7D187Q34469073-6EC9E550-E184-4CCE-A152-9F995AB95885Q34488624-8C3AAD2D-1735-46E6-A7FA-B0EF26C6825DQ34783589-F4ED5596-11AD-42DE-9C1F-12A8F57422A3Q35060920-532FB2BD-4BE9-4E70-8E89-8057333C82AFQ35228718-EA10AFC0-C72F-4DEF-8A59-B00F9081E711Q35247064-2A981094-42C6-49C1-92F7-E6AC192BFC8EQ35773665-A2356F91-24D5-4F15-9B11-DA9455BE016EQ35895492-A9B4AAF1-3360-4C50-91BC-B0668ADDF424Q36146681-E933E845-FBA6-4FA1-8A4C-2741A5CDF521Q36398911-5D23B274-9C24-46D9-9B41-BD59E8211945Q36756033-D5B3D8D7-84A6-4D7E-ADBC-CA69138B6A8EQ36952837-4312598A-4DA2-4FE2-B202-95AE478FCEFFQ37138681-1856F5BB-184C-4848-8306-33703899BF5DQ37148450-78E9878C-DA23-4CEF-BF26-34F3219739B6Q37253610-D6832C39-C9A2-4334-8FFA-882CAE3B4F07Q37486703-08C74E3C-6BCC-4D0E-83EE-BACAD1CEB14EQ37538184-EF511431-3F74-42DE-A756-52B372FAC3A6Q37997361-AAFD0E2C-0FAA-4596-8491-F8BE1736C8D9Q38011150-81BBF67A-09B8-423C-9F22-4867534D0381Q38096196-C62D346A-B909-49AA-9CDC-DE69D3F4C051Q38186602-1C320B54-F251-43A6-9831-4288945E707FQ38581859-F576510C-6589-404D-A75E-A5B985957262Q38692975-59616D01-F1FE-4C87-B54A-75D2B0FD92B2Q38710830-9CC581B9-181A-4040-BC65-775D761211B1Q38722983-8EF7EA08-1816-457B-906C-03BCE767DCD0Q38727591-C559AD95-2CB0-4729-B73B-F07484BF49DBQ38755537-96F46C28-F0BA-4D4E-8AE9-7052AC7DA5E9Q38792102-45F64FAB-D4F9-42D4-8382-5186525D915DQ38823023-2659E9BA-7732-4810-A362-7481C122EDD0Q38842569-6877BE9A-6471-4141-A554-6DA425F8DE26Q38849960-E99FCA2B-681F-4D6C-B9FB-0FD0BF1D6720Q38850101-35A894E1-CB4C-43FA-9D20-8D084DDA0B5C
P2860
Anticancer activity of metal complexes: involvement of redox processes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anticancer activity of metal complexes: involvement of redox processes.
@en
Anticancer activity of metal complexes: involvement of redox processes.
@nl
type
label
Anticancer activity of metal complexes: involvement of redox processes.
@en
Anticancer activity of metal complexes: involvement of redox processes.
@nl
prefLabel
Anticancer activity of metal complexes: involvement of redox processes.
@en
Anticancer activity of metal complexes: involvement of redox processes.
@nl
P2860
P50
P356
P1476
Anticancer activity of metal complexes: involvement of redox processes.
@en
P2860
P304
P356
10.1089/ARS.2010.3663
P577
2011-05-11T00:00:00Z